Concord Repatriation General Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Randomized phase III study of alisertib or investigator’s choice (selected single agent) in patients with relapsed or refractory peripheral T-cell lymphoma ¨

    Journal of Clinical Oncology